tablets Floksium are shown for treatment at the adult infections caused by microorganisms, sensitive to a levofloksatsin:
- sharp bacterial sinusitis;
- exacerbation of chronic bronchitis;
- community-acquired pneumonia;
- complicated infections of leather and soft tissues (in case of treatment of above-mentioned infections, medicament is used only when use of other antibacterial agents which usually appoint for initial treatment of these infections is impossible);
- complicated infections of urinary tract (including pyelonephritis);
- chronic bacterial prostatitis;
- uncomplicated cystitis;
- inhalation anthrax: post-contact prevention and treatment.
Structure
Active ingredient: levofloxacin;
1 tablet supports a levofloksatsin of the gemigidrat in terms of levofloxacin – 500 mg;
Excipients: krospovidon (poliplasdon XL), cellulose microcrystalline, potato starch, talc, a gipromeloza (hydroxypropyl-methyl cellulose), sodium lauryl sulfate, sodium stearate, mix for a covering of "Opadry II Yellow" 33G22507 krakhmalglikolit (type A), calcium (contains: triacetin; gipromeloza; lactose, monohydrate; titan dioxide (E 171); polyethyleneglycol; ferrous oxide yellow (E 172)).
Contraindication
- hypersensitivity to a levofloksatsin, other ftorkhinolona or to any component of medicine;
- epilepsy;
- injury of a sinew connected with the previous application of ftorkhinolon;
- children's age;
- period of pregnancy and feeding by a breast.
Route of administration
Pill Floksium is taken by 1-2 times a day. The dose depends on type, weight of an infection and sensitivity of the probable activator.
Floksium in this dosage form (tablet) can be applied to end of a course of therapy to patients who showed improvement in the course of primary Floksium medicament treatment, solution for injections, using at the same time the same doses.
Duration of treatment depends on the course of the disease and is no more than 14 days. It is recommended to continue use of medicine at least within 48-72 hours after normalization of body temperature or the destruction of activators confirmed with microbiological tests.
should swallow ofTablet Floksium without chewing, washing down with enough liquid. For convenience of dosing the tablet can be divided on a strip for division. It is possible to take a pill irrespective of consumption of food.
should use Drug not less than in 2 hours prior to or after use of salts of iron, salts of zinc, the antacids containing magnesium or aluminum, a didanozin (only for the forms containing aluminum or magnesium in buffer means) and the sukralfat.
toFeature of application
toPregnant
toIt is contraindicated.
toChildren
toDrug is contraindicated for application to children and teenagers because of risk of injury of an articulate cartilage.
Drivers
to Patients who run vehicles work aswith machines and mechanisms, it is necessary to consider possible undesirable reactions from nervous system (dizziness / vertigo, an okochenelost, drowsiness, confusion of consciousness, a disorder of vision and hearing, violation of processes of the movement).
Overdose
Symptoms of overdose of a levofloksatsin is violations from the central nervous system (confusion of consciousness, dizziness, violation of consciousness and convulsive attacks); reactions from digestive system, such as nausea and erosion of mucous membranes; lengthening of an interval of QT is possible. Hallucinations and a tremor are possible.
Treatment: symptomatic. It is necessary to provide monitoring of the ECG as prolongation of an interval of QT is possible. Mucous a stomach apply antiacid means to protection. The hemodialysis, including peritoneal dialysis or HAPD, is not effective for removal of a levofloksatsin from an organism. There are no specific antidotes.
Side effects
from mentality: often (from> 1/100 to <1/10) - insomnia.
from nervous system: often (from> 1/100 to <1/10) - a headache, dizziness.
from digestive tract: often (from> 1/100 to <1/10) - diarrhea, nausea, vomiting.
from a gepatobiliarny system: often (from> 1/100 to <1/10) - increase in activity of liver enzymes (ALT/nuclear heating plant, alkaline a phosphobasin, GGTP).
Interaction
Bioavailability of a levofloksatsin considerably decreases at simultaneous application with sukralfaty. If the patient needs to receive as sukralfat, and levofloxacin, it is better to accept sukralfat in 2 hours after reception of the tablets Floksium.
Knows that on pharmacokinetics of a levofloksatsin was not caused any clinically significant influence at application of a levofloksatsin together with calcium carbonate, digoxin, glibenclamide, ranitidine.
At simultaneous application with antagonists of vitamin K (for example with warfarin) was reported about increase in the international normalizing ratio (INR) and/or bleeding, which can be expressed. Despite this, at the patients receiving in parallel antagonists of vitamin K it is necessary to exercise control of indicators of coagulation.
Storage conditionsto Store
in original packing at a temperature not above 25 °C, out of children's reach.
Expiration date - 3 years.
Characteristics | |
Active ingredients | Levofloxacin |
Amount of active ingredient | 500 mg |
Applicant | Arterium |
Code of automatic telephone exchange | J01MA12 Levofloxacin |
Interaction with food | It doesn't matter |
Light sensitivity | Not sensitive |
Market status | The branded generic |
Origin | Chemical |
Prescription status | According to the prescription |
Primary packing | blister |
Producer | KIYEVMEDPREPARAT OF JOINT STOCK COMPANY |
Quantity in packing | 5 tablets |
Release form | tablets for internal use |
Route of administration | Oral |
Sign | Domestic |
Storage temperature | from 5 °C to 25 °C |
Trade name | Floksium |
Floksium of the tab. of p/o of 500 mg No. 5
- Product Code: 176428
- In Stock
- Ready to ship
-
$19.95